Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database.
Summary of "Venous thromboembolism and bleeding after total knee and hip arthroplasty. Findings from the Spanish National Discharge Database."
The impact of venous thromboembolism (VTE) and bleeding in patients undergoing major joint surgery has not been thoroughly studied. The Spanish National Discharge Database during the years 2005-2006 was used to assess the frequency and clinical impact of VTE and bleeding after elective total knee (TKA) or hip (THA) arthroplasty. Of 58,037 patients undergoing TKA, 0.18% (95% confidence interval [CI]: 0.15-0.22) were diagnosed with pulmonary embolism (PE), 0.57% (95%
0.51-0.63) with deep-vein thrombosis (DVT), 1.20% (95%
1.12-1.30) had bleeding complications, and 0.09% (95%
0.07-0.12) died. Of 54 patients who died, 20.4% (95%
10.7-35.4) had been diagnosed with PE, 3.70% (95%
0.63-11.7) with DVT, and 13.0% (95%
5.67-25.6) had bled. Of 31,769 patients undergoing elective THA, 0.23% (95%
0.18-0.29) were diagnosed with PE, 0.44% (95%
0.37-0.52) with DVT, 1.21% (95%
1.10-1.34) bled, and 0.16% (95%
0.12-0.21) died. Of 52 patients who died, 13.5% (95%
6.08-24.8) had been diagnosed with PE, and 9.61% (95%
3.52-21.3) had bled. On multivariable analysis, PE (odds ratio [OR]: 157; 95%
75-328), DVT (
1.5-27) and bleeding (
3.6-20) were independent predictors for death after TKA. After THA, only PE (
26-160) and bleeding (
2.3-17) predicted the risk for death. Bleeding, DVT, and PE, arising after TKA were all independent predictors for death. Their increase in risk was, however, substantially higher for PE. After THA, only PE and bleeding independently predicted death.
Prof. Manuel Monreal, MD, PhD, Servicio de Medicina Interna, Hospital Universitario Germans Trias i Pujol, 08916 Badalona (Barcelona), Spain, E-mail: email@example.com.
This article was published in the following journal.
Name: Thrombosis and haemostasis
- PubMed Source: http://www.ncbi.nlm.nih.gov/pubmed/21174008
- DOI: http://dx.doi.org/10.1160/TH10-10-0645
The purpose of this study was to describe the incidence of symptomatic venous thromboembolism (VTE), clinically-relevant bleeding, and death among a real-world population receiving warfarin prophylaxi...
Venous thromboembolism (VTE) remains a cause of significant morbidity and mortality following total hip arthroplasty (THA) and total knee arthroplasty (TKA). Prophylaxis significantly reduces the rate...
Our previous study showed, for the first time, that a guideline-recommended thromboprophylactic strategy reduced the prevalence of venous thromboembolism (VTE) including venous thromboembolism and pul...
There is a known bleeding risk with administration of the antiplatelet drug clopidogrel, but in certain patients the likelihood of thrombosis is too high to cease its administration perioperatively. T...
A significant proportion of patients with knee osteoarthritis have articular degeneration that is limited to the medial and patellofemoral compartments. The objective of this study was to compare clin...
The objective of this study is to assess the efficacy and safety of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective total k...
The primary objective is to demonstrate the efficacy of AVE5026 for prevention of Venous Thromboembolism (VTE) in patients undergoing elective Total Knee Replacement (TKR) surgery. The se...
The main objective of the study is to develop or validate a clinical prediction rule for major bleeding in patients on oral anticoagulant therapy who have been safely anticoagulated witho...
The goal of this study is to evaluate the comparative efficacy and safety of three different doses ( 110 mg, 150 mg, 220 mg) of BIBR 1048 (Dabigatran etexilate) orally, compared to placebo...
The purpose of this study is to evaluate long-term clinical and radiographic data between geometrically identical GVF and cross-linked polyethylene-bearing inserts in total knee arthroplas...
Medical and Biotech [MESH] Definitions
Replacement of the knee joint.
Impaired venous blood flow or venous return (venous stasis), usually caused by inadequate venous valves. Venous insufficiency often occurs in the legs, and is associated with EDEMA and sometimes with VENOUS STASIS ULCERS at the ankle.
Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure.
Obstruction of a vein or VEINS (embolism) by a blood clot (THROMBUS) in the blood stream.
A vascular anomaly characterized by a radial or wedge-shaped arrangement of dilated VEINS draining into a larger vein in the brain, spinal cord, or the meninges. Veins in a venous angioma are surrounded by normal nervous tissue, unlike a CENTRAL NERVOUS SYSTEM CAVERNOUS HEMANGIOMA that lacks intervening nervous tissue. Drainage of venous angioma is fully integrated with the body's venous system, therefore, in most cases there is no clinical signs and rare bleeding.